ARCHIVES

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Score Distribution, Other Charts, On P01s

October 2, 1992

In Brief: John Tamps New ACR President; Stanley Order ASTRO President Elect; Cairoli Heads Training

December 11, 1987

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013